Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Jerusalem
Clinical trial register · Israel

Clinical Trials in Jerusalem, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Israel and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2438 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2438
Studies in scope
all four open statuses
1243
Recruiting now
open to new participants
461
Lead sponsors
across recruiting studies
Top sites
Jerusalem 40 Rehovot 1 Haifa 1 Ramat Gan 1 Afula 1
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC80 AbbVie64 AstraZeneca52 Janssen Research & Development, LLC46 Hadassah Medical Organization40 Clear sponsor filter
Site location
Jerusalem40 Rehovot1 Haifa1 Ramat Gan1 Afula1
All 8 locations
Target enrolment
to

Trials with a site in Jerusalem

40 of 2438 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Israel
Start
Not yet open
Phase 1a/b Study of GPRC5D CART Therapy in Relapsed/Refractory Multiple Myeloma and Light-chain Amyloidosis
NCT07874334Relapsed/Refractory Multiple Myeloma (RRMM), Light-Chain Amyloidosis
Hadassah Medical Organization
Phase 1
160
Jerusalem
2026-11-01
Not yet open
Hadassah Medical Organization
Phase 1/2
15
Jerusalem
2026-09
Recruiting
Obstetric Risk Assessment & Cesarean-delivery in Labor Estimation Using Artificial Intelligence
NCT07430358Labor, Obstetric, Pregnancy, Cesarean Section Rate
Hadassah Medical Organization
Not applicable
400
Jerusalem
2026-05-19
Active, closed
Perioperative Prospective Follow Up Of Cannabis Consumers and Discrepancy Use
NCT07582445Cannabinoid, Discrepancy With Clinical Examination
Hadassah Medical Organization
Observational
600
Jerusalem
2026-05-06
Recruiting
Study of Naive HBI0101 CAR-T Therapy in Relapsed/Refractory Multiple Myeloma
NCT07333430Relapsed/Refractory Multiple Myeloma (MM)
Hadassah Medical Organization
Phase 1
60
Jerusalem
2026-01-07
Recruiting
Hadassah Medical Organization
Phase 1
10
Jerusalem
2025-12-11
Recruiting
The Computerized Retraining and Functional Treatment - Group Intervention
NCT07591857Cancer Related Cognitive Impairment, Breast Cancer Survivor
Hadassah Medical Organization
Not applicable
48
Jerusalem
2025-11-16
Recruiting
Hadassah Medical Organization
Phase 4
110
Haifa, Jerusalem, Ramat Gan
2024-12-09
Recruiting
Hadassah Medical Organization
Not applicable
100
Jerusalem
2024-11-05
Recruiting
Hadassah Medical Organization
Not applicable
500
Afula, Beersheba, Jerusalem, Kfar Saba, Tel HaShomer
2024-09-30
Recruiting
Subcutaneous Lavage in Cesarean Section
NCT06454227Surgical Site Infection
Hadassah Medical Organization
Not applicable
600
Jerusalem
2024-09-22
By invitation
Hadassah Medical Organization
Phase 2
50
Jerusalem
2024-08-20
Active, closed
Hadassah Medical Organization
Observational
1,000
Jerusalem
2024-08-01
Recruiting
Hadassah Medical Organization
Not applicable
120
Jerusalem
2024-05-28
Recruiting
Hadassah Medical Organization
Phase 4
303
Jerusalem, Rehovot
2024-03-12
Active, closed
Hadassah Medical Organization
Not applicable
64
Jerusalem
2024-02-21
Active, closed
Hadassah Medical Organization
Observational
50
Jerusalem
2023-11-10
Recruiting
Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia
NCT05640700Human Papilloma Virus, Vaginal Flora Imbalance, Cancer Cervix Uterus, Cervical Dysplasia
Hadassah Medical Organization
Observational
90
Jerusalem
2022-11-09
Recruiting
Hadassah Medical Organization
Not applicable
100
Jerusalem
2022-10-17
Recruiting
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
NCT05296564Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV, Triple Negative Breast Cancer
DrugsAldesleukin·Cytoxan·Cyclophosphamide
Hadassah Medical Organization
Phase 1/2
3
Jerusalem
2022-04-01
Active, closed
Hadassah Medical Organization
Observational
40
Jerusalem
2022-02-15
Active, closed
Hadassah Medical Organization
Observational
50
Jerusalem
2021-09-01
Recruiting
Hadassah Medical Organization
Not applicable
400
Jerusalem
2021-08-19
Recruiting
Hadassah Medical Organization
Observational
40
Jerusalem
2021-08-01
Recruiting
Hadassah Medical Organization
Not applicable
162
Jerusalem
2021-03-09
Active, closed
NXC-201 (formerly HBI0101) Multiple Myeloma
NCT04720313Dose Escalation and Safety
Hadassah Medical Organization
Phase 1
160
Jerusalem
2021-01-01
Active, closed
Hadassah Medical Organization
Phase 1/2
30
Jerusalem
2020-08-20
Recruiting
Hadassah Medical Organization
Not applicable
150
Jerusalem
2018-07-28
Recruiting
Hadassah Medical Organization
Phase 3
200
Jerusalem
2018-01-07
Recruiting
Hadassah Medical Organization
Not applicable
300
Jerusalem
2016-12-29
Recruiting
Hadassah Medical Organization
Phase 1/2
50
Jerusalem
2013-05
Recruiting
Hadassah Medical Organization
Observational
250
Jerusalem
2011-09
Recruiting
Hadassah Medical Organization
Observational
120
Jerusalem
2009-04
Recruiting
Hadassah Medical Organization
Observational
2,000
Jerusalem
2009-03-09
Recruiting
Use of Existing Fibroblast Cells to Convert to Induced Pluripotent Stem Cells
NCT00801372Pregnant, Healthy Females, Healthy Male Newborns
Hadassah Medical Organization
Observational
1
Jerusalem
2008-11
Recruiting
Hadassah Medical Organization
Observational
25
Jerusalem
2008-11
Recruiting
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
NCT00722228Colorectal Cancer, Ovarian Cancer, Gastric Cancer, Breast Cancer
Hadassah Medical Organization
Phase 1/2
50
Jerusalem
2008-07
Recruiting
Hadassah Medical Organization
Observational
70
Jerusalem
2004-04-06
Recruiting
Hadassah Medical Organization
Not applicable
1,000
Jerusalem
2003-09
Recruiting
Hadassah Medical Organization
Observational
80
Jerusalem
2002-07-07
Rows per page Showing 1–40 of 40
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Israeli investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-israel/city/jerusalem

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Israel and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,438 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 40 of those studies with a site in Jerusalem that also match the filters currently applied.

How many clinical trials are recruiting in Jerusalem?

29 of the 40 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 2 have not yet opened recruitment, 8 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Jerusalem), 40 studies
PhaseStudiesRecruitingShare
Observational14935%
Not applicable131232.5%
Phase 1/25312.5%
Phase 14210%
Phase 4225%
Phase 2102.5%
Phase 3112.5%

Most active sponsors

Lead sponsors with the most studies (Jerusalem)
Lead sponsorStudiesRecruiting
Hadassah Medical Organization4029
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.